Axsome Therapeutics (AXSM) Revenue (2022 - 2026)
Axsome Therapeutics (AXSM) posted Revenue of $191.2 million for Q1 2026, down 2.45% sequentially from $196.0 million in Q4 2025, and up 57.42% YoY from $121.5 million in Q1 2025.
Axsome Therapeutics (AXSM) Revenue (2022 - 2026) Analysis & Trends
Axsome Therapeutics has reported Revenue for 5 years, with the latest figure at $191.2 million in Q1 2026.
- Quarterly Revenue rose 57.42% year-over-year to $191.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $708.2 million (up 125.63% YoY) and the FY2025 annual result came in at $638.5 million, up 65.55% from the prior year.
- Revenue retreated to $191.2 million in Q1 2026 per AXSM's latest filing, from $196.0 million in the prior quarter.
- Over five years, Revenue peaked at $196.0 million in Q4 2025 and troughed at $500000.0 in Q4 2024.
- A 5-year average of $88.6 million and a median of $81.1 million in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue slumped 99.3% in 2024, then jumped 39099.8% in 2025.
- Over 5 years, Revenue stood at $24.4 million in 2022, then surged by 193.5% to $71.5 million in 2023, then plunged by 99.3% to $500000.0 in 2024, then surged by 39099.8% to $196.0 million in 2025, then declined by 2.45% to $191.2 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $191.2 million, $196.0 million, and $171.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Axsome Therapeutics | 11.19 Bn | 10.87 Bn | 204.81 Mn | 218.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 218.38 Mn |
| Mar 31, 2026 | 191.20 Mn |
| Dec 31, 2025 | 196.00 Mn |
| Sep 30, 2025 | 170.99 Mn |
| Jun 30, 2025 | 150.04 Mn |
| Mar 31, 2025 | 121.46 Mn |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 104.76 Mn |
| Jun 30, 2024 | 87.17 Mn |
| Mar 31, 2024 | 75.00 Mn |
| Dec 31, 2023 | 71.53 Mn |
| Sep 30, 2023 | 57.79 Mn |
| Jun 30, 2023 | 46.70 Mn |
| Mar 31, 2023 | 94.58 Mn |
| Dec 31, 2022 | 24.37 Mn |
| Sep 30, 2022 | 16.85 Mn |
| Jun 30, 2022 | 8.82 Mn |